Proctor & Gamble Recalls Pantene, Herbal Essences Products Due to Benzene
MONDAY, Dec. 20, 2021 (HealthDay News) – Proctor & Gamble has voluntarily recalled several dry shampoo sprays and hair conditioner spray products with brand names Pantene, Herbal Essences, Aussie and Waterless because of benzene contamination.
This follows an earlier recall of some aerosol spray Old Spice and Secret products, also manufactured by Proctor & Gamble.
Benzene is a cancer-causing chemical that can be inhaled and absorbed through the skin. It can cause leukemia, blood cancer of the bone marrow and blood disorders that can be life-threatening.
The recalled products -- all in aerosol cans -- were distributed throughout the United States. Some of the products under recall are Pantene Smooth Talker Dry Conditioning Oil; Aussie Smooth Vibes Dry Conditioner; Herbal Essences Blue Ginger Refresh Dry Shampoo, and Waterless Dry Shampoo No Residue. Previously, Hair Food dry shampoo was also discontinued due to benzene's presence.
Consumers should stop using and discard the specific products cited in the recall, P&G says. A full list of all products with the relevant UPC codes, names and descriptions are listed on the U.S. Food and Drug Administration Website.
The company began a review of its aerosol products after recent reports showed traces of benzene in some aerosol spray offerings. It has not received any reports of harm from their use.
"While benzene is not an ingredient in any of our products, our review showed that unexpected levels of benzene came from the propellant that sprays the product out of the can," Proctor & Gamble said in a statement.
Individuals should contact their health care providers if they have any problems they believe may be related to use of the products. Users can call the company’s Consumer Care team at 1-888-674-3631 from 9 a.m. 6 p.m. EST
Monday through Friday with other questions.
More information
MD Anderson Cancer Center has more on the links between personal care products and cancer.
SOURCE: Proctor & Gamble, news release, Dec. 17, 2021
Related Posts
FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps
TUESDAY, Sept. 20, 2022 (HealthDay News) -- The U.S. Food and Drug...
Do Older Patients Need Radiation Rx After Breast Cancer Surgery?
THURSDAY, Feb. 16, 2023 (HealthDay News) -- Many older women with early-stage...
La FDA aprueba la actualización de la vacuna contra COVID de Novavax
JUEVES, 5 de octubre de 2023 (HealthDay News) -- Los reguladores federales...
Nuevas pistas sobre un brote reciente de hepatitis en niños
VIERNES, 31 de marzo de 2023 (HealthDay News) -- Una nueva investigación ha...